542 related articles for article (PubMed ID: 9413226)
1. Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas.
Korabiowska M; Betke H; Kellner S; Stachura J; Schauer A
Anticancer Res; 1997; 17(5A):3697-700. PubMed ID: 9413226
[TBL] [Abstract][Full Text] [Related]
2. Growth arrest DNA damage gene expression in naevi.
Korabiowska M; Brinck U; Betke H; Droese M; Berger H
In Vivo; 1999; 13(3):247-50. PubMed ID: 10459501
[TBL] [Abstract][Full Text] [Related]
3. Loss of growth arrest DNA damage genes expression in oral melanomas.
Korabiowska M; Betke H; Brinck U; Grohmann U; Hönig JF; Droese M
In Vivo; 1999; 13(6):483-5. PubMed ID: 10757041
[TBL] [Abstract][Full Text] [Related]
4. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
5. Relation between two independent DNA-repair pathways in different groups of naevi.
Korabiowska M; Brinck U; Kellner S; Droese M; Berger H
In Vivo; 1999; 13(3):243-5. PubMed ID: 10459500
[TBL] [Abstract][Full Text] [Related]
6. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
7. Increased GADD gene expression in human colon epithelial cells exposed to deoxycholate.
Scott DW; Mutamba S; Hopkins RG; Loo G
J Cell Physiol; 2005 Jan; 202(1):295-303. PubMed ID: 15316935
[TBL] [Abstract][Full Text] [Related]
8. Induction of GADD gene expression by phenethylisothiocyanate in human colon adenocarcinoma cells.
Powolny A; Takahashi K; Hopkins RG; Loo G
J Cell Biochem; 2003 Dec; 90(6):1128-39. PubMed ID: 14635187
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
10. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.
Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Valerie K; Dent P; Fisher PB
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10054-9. PubMed ID: 12114539
[TBL] [Abstract][Full Text] [Related]
11. Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Kellner S; Marx D; Schauer A
Anticancer Res; 1995; 15(3):885-9. PubMed ID: 7645976
[TBL] [Abstract][Full Text] [Related]
12. Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.
Korabiowska M; Brinck U; Ruschenburg I; Schlott T; Droese M; Stachura J
Pol J Pathol; 1999; 50(1):17-21. PubMed ID: 10412270
[TBL] [Abstract][Full Text] [Related]
13. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
Poyraz A; Akyürek N; Gönül II; Erdem O
J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
[TBL] [Abstract][Full Text] [Related]
14. The p53-dependent gamma-ray response of GADD45.
Zhan Q; Bae I; Kastan MB; Fornace AJ
Cancer Res; 1994 May; 54(10):2755-60. PubMed ID: 8168107
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cerbB3 in naevi and malignant melanomas.
Korabiowska M; Mirecka J; Brinck U; Hoefer K; Marx D; Schauer A
Anticancer Res; 1996; 16(1):471-4. PubMed ID: 8615656
[TBL] [Abstract][Full Text] [Related]
16. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
17. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
18. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes.
Gujuluva CN; Baek JH; Shin KH; Cherrick HM; Park NH
Oncogene; 1994 Jul; 9(7):1819-27. PubMed ID: 8208528
[TBL] [Abstract][Full Text] [Related]
19. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
20. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes.
Velasco-Miguel S; Buckbinder L; Jean P; Gelbert L; Talbott R; Laidlaw J; Seizinger B; Kley N
Oncogene; 1999 Jan; 18(1):127-37. PubMed ID: 9926927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
